Baker Tilly Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,191
Closed -$201K – 292
2026
Q2
$201K Buy
+2,191
New +$192K 0.04% 281
2024
Q3
– Sell
-3,407
Closed -$331K – 242
2024
Q2
$331K Sell
3,407
-3,319
-49% -$306K 0.14% 182
2024
Q1
$606K Sell
6,726
-225
-3% -$19.1K 0.11% 210
2023
Q4
$554K Buy
+6,951
New +$523K 0.09% 259
2022
Q4
– Sell
-3,610
Closed -$254K – 544
2022
Q3
$254K Sell
3,610
-31
-0.9% -$2.43K 0.03% 435
2022
Q2
$292K Buy
+3,641
New +$285K 0.04% 416
2022
Q1
– Sell
-11,499
Closed -$981K – 531
2021
Q4
$981K Sell
11,499
-670
-6% -$52.3K 0.11% 199
2021
Q3
$920K Buy
12,169
+3,763
+45% +$299K 0.12% 182
2021
Q2
$684K Buy
8,406
+127
+2% +$10.4K 0.11% 205
2021
Q1
$653K Buy
+8,279
New +$649K 0.13% 194

Other funds holding CL

Baker Tilly Wealth Management's CL Position: Q3 2026 in Review

Baker Tilly Wealth Management sold out of Colgate-Palmolive (CL) in Q3 2026, closing a stake of 2,191 shares — an estimated $201K sold.

Baker Tilly Wealth Management first reported a position in CL in Q1 2021 and held it in 10 quarters. The position peaked at $981K in Q4 2021. 1,804 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Baker Tilly Wealth Management reported no remaining Colgate-Palmolive position as of Q3 2026 after selling out during the quarter.
  • Baker Tilly Wealth Management sold 2,191 Colgate-Palmolive shares in Q3 2026, an estimated $201K.
  • Baker Tilly Wealth Management first reported a position in Colgate-Palmolive in Q1 2021 and held it in 10 quarters.
  • Baker Tilly Wealth Management's Colgate-Palmolive position peaked at $981K in Q4 2021.
  • 1,804 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.